Proteas Bioanalytics Inc.

From a single drop of blood, Proteas Bioanalytics is able to detect the presence of human diseases at their earliest stage, before the onset of symptoms. Our technologies will also provide objective guidance to implement effective treatment options. Proteas Bioanalytics has also developed advanced technologies for the in-depth analysis and biological understanding of single cells and tissue biopsy specimens that complement and validates our blood-based analysis platform. The field of blood and single-cell proteomics offers a tremendous opportunity to reshape the diagnosis and treatment of almost all diseases. Currently used proteomics technologies do not meet the stringent FDA performance criteria due to the high complexity and heterogeneity of human blood, tissue and cells and their analysis method. The Proteas Bioanalytics proprietary proteomics technology: ▪ includes the analysis of all proteins expressed in blood, cells and tissues during healthy or diseased situations ▪ leverages 30-years of our published methods and overcomes previous limitations ▪ leads to the development of novel protein-based biological signatures with actionable clinical importance ▪ leads to the development of novel proteins markers for monitoring the response to treatment (pharmacology, immunotherapy, nutritional intervention, lifestyle intervention) ➢ We are both a platform and disease-specific biosignature with assay development company ➢ Our core proteomics technology can be partnered across indications to pharma and biotech companies, while our internal biomarker platforms will be developed for high unmet needs in the clinical arena The Proteas Bioanalytics team has extensive industrial, academic, and government experience in research and development, partnering, biology, pharmacology, analytical chemistry, nanotechnology, mathematics and artificial intelligence that will promotes the development of a state-of-the-art and innovative platforms.

Evolute Bioscience

Evolute Bioscience is an initiative by NIT alumini to establish a technicalized environment that focus on the research needs and prepare the students to meet the industrial requirements in biotechnology. This is a startup organization aims to provide technical hands-on opportunities to students pursuing undergraduate & post graduate studies in life science, pharma and biotechnology also to furnish an environment to effectively utilize lab facilities for research scholars. Our focus is to bridge the gap between theoretical learning and practical implementation by introducing all possible technical resources to the students. The preliminary work of the organization is to cater the research gaps and train the students accordingly for industrial employment.

Nattaro Labs AB

Nattaro Labs AB is focused on effective, proprietary solutions for the eradication of bedbugs using cutting-edge knowledge in prevention, detection and control of infestations using new non-toxic techniques. Nattaro Labs unique experience in bed bug research, chemical ecology, and insect behavior positions us as leading edge experts in delivering broadly marketable, valuable solutions for the rapidly growing, worldwide bed bug infestation problem. Our unique experience in bed bug research, positions us as one of the world-leading experts in bed bug chemical ecology and behaviour with cutting-edge knowledge in how to successfully prevent, detect and control bed bug infestations by using new non-toxic techniques, giving us the prospect of becoming a major player. Our target groups are, besides the pest control professionals, the industries most affected by infestations, primarily Hotels and other Accommodation providers in the Travel industry. Nattaro Labs business idea, being experts on the subject, is to develop and provide solutions with which our customers will be able to effectively detect, control and prevent bed bug infestations. Our products will be environmentally sustainable and based on extensive and advanced research on pheromones and kairomones, i.e. chemical cues essential for orientation in bed bugs. A unique strength is also our laboratory with a bed bug culture, on which the products are tested on live bed bugs. We will provide the market with alternative strategies and tools to be used to handle bed bug infestations; i.e. Prevention, detection and control.

Genefitletics

Genefitletics, a biotech company founded in 2019, uses system biology & mathematics to accelerate the speed at which application of scientific discoveries & molecular data driven personalization empowers people to reclaim control of their health Harnessing the power of next generation sequencing, cloud computing & machine learning, Genefitletics's system biology platform measures & analyzes biology & chemistry of an individual at molecular level to deeply understand origin & progression of chronic diseases in order to prevent, diagnose them early, stop their progression and reverse them. This data driven platform that precisely characterize human-microbial interactions : 1)Provide patients with unique molecular insights & precision nutrition interventions to bring their body back into homeostasis 2)Give healthcare practitioners access to hard to detect pre disease signals which conventional clinical diagnostic tests cannot identify, enabling them to align their interventions with patient’s unique biochemical individuality The company is led by a team of researchers, inventors, industry experts & passionate & curious entrepreneurs with a combined leadership & executive experience of 30 + years who are on a journey to impact human health. The company has been awarded as : 1) Best chronic illness prevention R &D Biotech company 2024-South Asia by Global Health & Pharma 2)Biotech Innovation Excellence Award 2024- by Global Heath & Pharma 3)Microbiome Therapeutics as a service platform, 2023 by AWS & MINFY in association with CNBC 4)Chronic Illness Prevention R&D Biotech Company- Asia,2022 by Global Health Pharma 5)Specialist Biotech Company of the year, CorporateLiveWire, Global Awards, 2022/23 6) Microbiome Therapeutics as a service platform, 2023 by Global Health & Pharma 7) Chronic Illness Prevention R&D Biotech Company of the Year 2023 - Asia by AI Global Media

nanomik biotechnology

Nanomik, develops & produces microencapsulated biopesticides for food and agricultural products that protects them against food spoilage without changing their quality. Today whole World suffers from the food waste. Approximately 30% of fresh fruits and vegetables are lost before coming to the stall. Economic impact of mentioned losses is beyond 1.3 Billion $ annually. In traditional preservation, very harmful chemicals and their synthetic derivatives are used for protection; however, their usage is limited because of their negative effects to the human. Amounts allowed for usage are not sufficient for the long-term protection. These chemicals and harmful microorganism toxins are the main problems for the export of agricultural products because of their harmful effects to human and nature. Our company Nanomik aims to show that all food and agricultural products can be protected naturally without harmful chemicals and food waste can be decreased to the minimal levels. Mainly, the World with more natural products and healthy foods is aimed by Nanomik!